Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 85

1.

Exploring the radiosensitizing potential of magnetotherapy: a pilot study in breast cancer cells.

Salinas-Asensio MM, Ríos-Arrabal S, Artacho-Cordón F, Olivares-Urbano MA, Calvente I, León J, Núñez MI.

Int J Radiat Biol. 2019 Sep;95(9):1337-1345. doi: 10.1080/09553002.2019.1619951. Epub 2019 Jun 17.

PMID:
31140889
2.

PI3-kinase pathway biomarkers in oral cancer and tumor immune cells.

Ibrahim MY, Nunez MI, Harun N, Lee JJ, El-Naggar AK, Ferrarotto R, Wistuba I, Myers J, Glisson BS, William WN Jr.

Head Neck. 2019 Mar;41(3):615-622. doi: 10.1002/hed.25350. Epub 2018 Dec 16.

PMID:
30556200
3.

AA-NAT, MT1 and MT2 Correlates with Cancer Stem-Like Cell Markers in Colorectal Cancer: Study of the Influence of Stage and p53 Status of Tumors.

Casado J, Iñigo-Chaves A, Jiménez-Ruiz SM, Ríos-Arrabal S, Carazo-Gallego Á, González-Puga C, Núñez MI, Ruíz-Extremera Á, Salmerón J, León J.

Int J Mol Sci. 2017 Jun 11;18(6). pii: E1251. doi: 10.3390/ijms18061251.

4.

Radiofrequency exposure in the Neonatal Medium Care Unit.

Calvente I, Vázquez-Pérez A, Fernández MF, Núñez MI, Múñoz-Hoyos A.

Environ Res. 2017 Jan;152:66-72. doi: 10.1016/j.envres.2016.09.019. Epub 2016 Oct 12.

PMID:
27741450
5.

Defining Benchmarks for Major Liver Surgery: A multicenter Analysis of 5202 Living Liver Donors.

Rössler F, Sapisochin G, Song G, Lin YH, Simpson MA, Hasegawa K, Laurenzi A, Sánchez Cabús S, Nunez MI, Gatti A, Beltrame MC, Slankamenac K, Greig PD, Lee SG, Chen CL, Grant DR, Pomfret EA, Kokudo N, Cherqui D, Olthoff KM, Shaked A, García-Valdecasas JC, Lerut J, Troisi RI, De Santibanes M, Petrowsky H, Puhan MA, Clavien PA.

Ann Surg. 2016 Sep;264(3):492-500. doi: 10.1097/SLA.0000000000001849.

6.

Does exposure to environmental radiofrequency electromagnetic fields cause cognitive and behavioral effects in 10-year-old boys?

Calvente I, Pérez-Lobato R, Núñez MI, Ramos R, Guxens M, Villalba J, Olea N, Fernández MF.

Bioelectromagnetics. 2016 Jan;37(1):25-36. doi: 10.1002/bem.21951.

PMID:
26769168
7.

Valproic acid modulates radiation-enhanced matrix metalloproteinase activity and invasion of breast cancer cells.

Artacho-Cordón F, Ríos-Arrabal S, Olivares-Urbano MA, Storch K, Dickreuter E, Muñoz-Gámez JA, León J, Calvente I, Torné P, Salinas Mdel M, Cordes N, Núñez MI.

Int J Radiat Biol. 2015;91(12):946-56. doi: 10.3109/09553002.2015.1087067. Epub 2015 Oct 22.

PMID:
26490761
8.

Patient and staff dosimetry during radiographic procedures in an intensive care unit.

Fernández R, Moreno-Torres M, Contreras AM, Núñez MI, Guirado D, Peñas L.

J Radiol Prot. 2015 Sep;35(3):727-32. doi: 10.1088/0952-4746/35/3/727. Epub 2015 Sep 7.

PMID:
26344655
9.

Cell membrane CD44v6 levels in squamous cell carcinoma of the lung: association with high cellular proliferation and high concentrations of EGFR and CD44v5.

Ruibal Á, Aguiar P, Del Río MC, Nuñez MI, Pubul V, Herranz M.

Int J Mol Sci. 2015 Feb 18;16(3):4372-8. doi: 10.3390/ijms16034372.

10.

Outdoor characterization of radio frequency electromagnetic fields in a Spanish birth cohort.

Calvente I, Fernández MF, Pérez-Lobato R, Dávila-Arias C, Ocón O, Ramos R, Ríos-Arrabal S, Villalba-Moreno J, Olea N, Núñez MI.

Environ Res. 2015 Apr;138:136-43. doi: 10.1016/j.envres.2014.12.013. Epub 2015 Feb 21.

PMID:
25707018
11.

Receptor tyrosine kinase EphA5 is a functional molecular target in human lung cancer.

Staquicini FI, Qian MD, Salameh A, Dobroff AS, Edwards JK, Cimino DF, Moeller BJ, Kelly P, Nunez MI, Tang X, Liu DD, Lee JJ, Hong WK, Ferrara F, Bradbury AR, Lobb RR, Edelman MJ, Sidman RL, Wistuba II, Arap W, Pasqualini R.

J Biol Chem. 2015 Mar 20;290(12):7345-59. doi: 10.1074/jbc.M114.630525. Epub 2015 Jan 26.

12.

Characterization of indoor extremely low frequency and low frequency electromagnetic fields in the INMA-Granada cohort.

Calvente I, Dávila-Arias C, Ocón-Hernández O, Pérez-Lobato R, Ramos R, Artacho-Cordón F, Olea N, Núñez MI, Fernández MF.

PLoS One. 2014 Sep 5;9(9):e106666. doi: 10.1371/journal.pone.0106666. eCollection 2014.

13.

Impact of decitabine on immunohistochemistry expression of the putative tumor suppressor genes FHIT, WWOX, FUS1 and PTEN in clinical tumor samples.

Stewart DJ, Nunez MI, Jelinek J, Hong D, Gupta S, Aldaz M, Issa JP, Kurzrock R, Wistuba II.

Clin Epigenetics. 2014 Jul 3;6(1):13. doi: 10.1186/1868-7083-6-13. eCollection 2014.

14.

Expression profiling stratifies mesothelioma tumors and signifies deregulation of spindle checkpoint pathway and microtubule network with therapeutic implications.

Suraokar MB, Nunez MI, Diao L, Chow CW, Kim D, Behrens C, Lin H, Lee S, Raso G, Moran C, Rice D, Mehran R, Lee JJ, Pass HI, Wang J, Momin AA, James BP, Corvalan A, Coombes K, Tsao A, Wistuba II.

Ann Oncol. 2014 Jun;25(6):1184-92. doi: 10.1093/annonc/mdu127. Epub 2014 Mar 24.

15.

Membrane carbonic anhydrase IX expression and relapse risk in resected stage I-II non-small-cell lung cancer.

Stewart DJ, Nunez MI, Behrens C, Liu D, Lin YH, Lee JJ, Roth J, Heymach J, Swisher SG, Hong WK, Wistuba II.

J Thorac Oncol. 2014 May;9(5):675-84. doi: 10.1097/JTO.0000000000000148.

16.

ESR1 gene promoter region methylation in free circulating DNA and its correlation with estrogen receptor protein expression in tumor tissue in breast cancer patients.

Martínez-Galán J, Torres-Torres B, Núñez MI, López-Peñalver J, Del Moral R, Ruiz De Almodóvar JM, Menjón S, Concha A, Chamorro C, Ríos S, Delgado JR.

BMC Cancer. 2014 Feb 4;14:59. doi: 10.1186/1471-2407-14-59.

17.

Decitabine impact on the endocytosis regulator RhoA, the folate carriers RFC1 and FOLR1, and the glucose transporter GLUT4 in human tumors.

Stewart DJ, Nunez MI, Jelinek J, Hong D, Gupta S, Issa JP, Wistuba II, Kurzrock R.

Clin Epigenetics. 2014 Jan 9;6(1):2. doi: 10.1186/1868-7083-6-2.

18.

Involvement of free radicals in breast cancer.

Ríos-Arrabal S, Artacho-Cordón F, León J, Román-Marinetto E, Del Mar Salinas-Asensio M, Calvente I, Núñez MI.

Springerplus. 2013 Aug 27;2:404. doi: 10.1186/2193-1801-2-404. Review.

19.

Could radiotherapy effectiveness be enhanced by electromagnetic field treatment?

Artacho-Cordón F, Salinas-Asensio Mdel M, Calvente I, Ríos-Arrabal S, León J, Román-Marinetto E, Olea N, Núñez MI.

Int J Mol Sci. 2013 Jul 17;14(7):14974-95. doi: 10.3390/ijms140714974. Review.

20.

Abrogation of the p38 MAPK α signaling pathway does not promote radioresistance but its activity is required for 5-Fluorouracil-associated radiosensitivity.

de la Cruz-Morcillo MA, García-Cano J, Arias-González L, García-Gil E, Artacho-Cordón F, Ríos-Arrabal S, Valero ML, Cimas FJ, Serrano-Oviedo L, Villas MV, Romero-Fernández J, Núñez MI, Sánchez-Prieto R.

Cancer Lett. 2013 Jul 10;335(1):66-74. doi: 10.1016/j.canlet.2013.01.050. Epub 2013 Feb 8.

PMID:
23403078
21.

Prognostic significance of combinations of RNA-dependent protein kinase and EphA2 biomarkers for NSCLC.

Guo C, Shao R, Correa AM, Behrens C, Johnson FM, Raso MG, Prudkin L, Solis LM, Nunez MI, Fang B, Roth JA, Wistuba II, Swisher SG, Lin T, Pataer A.

J Thorac Oncol. 2013 Mar;8(3):301-8. doi: 10.1097/JTO.0b013e318282def7.

22.

Matrix metalloproteinases: potential therapy to prevent the development of second malignancies after breast radiotherapy.

Artacho-Cordón F, Ríos-Arrabal S, Lara PC, Artacho-Cordón A, Calvente I, Núñez MI.

Surg Oncol. 2012 Sep;21(3):e143-51. doi: 10.1016/j.suronc.2012.06.001. Epub 2012 Jun 28. Review.

PMID:
22749313
23.

High expression of folate receptor alpha in lung cancer correlates with adenocarcinoma histology and EGFR [corrected] mutation.

Nunez MI, Behrens C, Woods DM, Lin H, Suraokar M, Kadara H, Hofstetter W, Kalhor N, Lee JJ, Franklin W, Stewart DJ, Wistuba II.

J Thorac Oncol. 2012 May;7(5):833-40. doi: 10.1097/JTO.0b013e31824de09c. Erratum in: J Thorac Oncol. 2012 Jun;7(6):1065.

24.

Divergent genomic and epigenomic landscapes of lung cancer subtypes underscore the selection of different oncogenic pathways during tumor development.

Lockwood WW, Wilson IM, Coe BP, Chari R, Pikor LA, Thu KL, Solis LM, Nunez MI, Behrens C, Yee J, English J, Murray N, Tsao MS, Minna JD, Gazdar AF, Wistuba II, MacAulay CE, Lam S, Lam WL.

PLoS One. 2012;7(5):e37775. doi: 10.1371/journal.pone.0037775. Epub 2012 May 21.

25.

Phase I clinical trial of systemically administered TUSC2(FUS1)-nanoparticles mediating functional gene transfer in humans.

Lu C, Stewart DJ, Lee JJ, Ji L, Ramesh R, Jayachandran G, Nunez MI, Wistuba II, Erasmus JJ, Hicks ME, Grimm EA, Reuben JM, Baladandayuthapani V, Templeton NS, McMannis JD, Roth JA.

PLoS One. 2012;7(4):e34833. doi: 10.1371/journal.pone.0034833. Epub 2012 Apr 25.

26.

Tumor microenvironment and breast cancer progression: a complex scenario.

Artacho-Cordón A, Artacho-Cordón F, Ríos-Arrabal S, Calvente I, Núñez MI.

Cancer Biol Ther. 2012 Jan 1;13(1):14-24. doi: 10.4161/cbt.13.1.18869. Review.

PMID:
22336584
27.

Combined low initial DNA damage and high radiation-induced apoptosis confers clinical resistance to long-term toxicity in breast cancer patients treated with high-dose radiotherapy.

Henríquez-Hernández LA, Carmona-Vigo R, Pinar B, Bordón E, Lloret M, Núñez MI, Rodríguez-Gallego C, Lara PC.

Radiat Oncol. 2011 Jun 6;6:60. doi: 10.1186/1748-717X-6-60.

28.

Radiation induced apoptosis and initial DNA damage are inversely related in locally advanced breast cancer patients.

Pinar B, Henríquez-Hernández LA, Lara PC, Bordon E, Rodriguez-Gallego C, Lloret M, Nuñez MI, De Almodovar MR.

Radiat Oncol. 2010 Sep 24;5:85. doi: 10.1186/1748-717X-5-85.

29.

Exposure to electromagnetic fields (non-ionizing radiation) and its relationship with childhood leukemia: a systematic review.

Calvente I, Fernandez MF, Villalba J, Olea N, Nuñez MI.

Sci Total Environ. 2010 Jul 15;408(16):3062-9. doi: 10.1016/j.scitotenv.2010.03.039. Epub 2010 May 7. Review.

PMID:
20451240
30.

Rhomboid domain containing 2 (RHBDD2): a novel cancer-related gene over-expressed in breast cancer.

Abba MC, Lacunza E, Nunez MI, Colussi A, Isla-Larrain M, Segal-Eiras A, Croce MV, Aldaz CM.

Biochim Biophys Acta. 2009 Oct;1792(10):988-97. doi: 10.1016/j.bbadis.2009.07.006. Epub 2009 Jul 17.

31.

Decitabine effect on tumor global DNA methylation and other parameters in a phase I trial in refractory solid tumors and lymphomas.

Stewart DJ, Issa JP, Kurzrock R, Nunez MI, Jelinek J, Hong D, Oki Y, Guo Z, Gupta S, Wistuba II.

Clin Cancer Res. 2009 Jun 1;15(11):3881-8. doi: 10.1158/1078-0432.CCR-08-2196. Epub 2009 May 26.

32.

Quantitative detection of methylated ESR1 and 14-3-3-sigma gene promoters in serum as candidate biomarkers for diagnosis of breast cancer and evaluation of treatment efficacy.

Martínez-Galán J, Torres B, Del Moral R, Muñoz-Gámez JA, Martín-Oliva D, Villalobos M, Núñez MI, Luna Jde D, Oliver FJ, Ruiz de Almodóvar JM.

Cancer Biol Ther. 2008 Jun;7(6):958-65. Epub 2008 Mar 20.

PMID:
18379196
33.

CtIP silencing as a novel mechanism of tamoxifen resistance in breast cancer.

Wu M, Soler DR, Abba MC, Nunez MI, Baer R, Hatzis C, Llombart-Cussac A, Llombart-Bosch A, Aldaz CM.

Mol Cancer Res. 2007 Dec;5(12):1285-95. doi: 10.1158/1541-7786.MCR-07-0126.

34.

Radiation-induced DNA damage as a predictor of long-term toxicity in locally advanced breast cancer patients treated with high-dose hyperfractionated radical radiotherapy.

Pinar B, Lara PC, Lloret M, Bordón E, Núñez MI, Villalobos M, Guerrero R, Luna JD, Ruiz de Almodóvar JM.

Radiat Res. 2007 Oct;168(4):415-22.

PMID:
17903032
35.

Breast cancer molecular signatures as determined by SAGE: correlation with lymph node status.

Abba MC, Sun H, Hawkins KA, Drake JA, Hu Y, Nunez MI, Gaddis S, Shi T, Horvath S, Sahin A, Aldaz CM.

Mol Cancer Res. 2007 Sep;5(9):881-90.

36.

WWOX hypomorphic mice display a higher incidence of B-cell lymphomas and develop testicular atrophy.

Ludes-Meyers JH, Kil H, Nuñez MI, Conti CJ, Parker-Thornburg J, Bedford MT, Aldaz CM.

Genes Chromosomes Cancer. 2007 Dec;46(12):1129-36.

37.

GATA3 protein as a MUC1 transcriptional regulator in breast cancer cells.

Abba MC, Nunez MI, Colussi AG, Croce MV, Segal-Eiras A, Aldaz CM.

Breast Cancer Res. 2006;8(6):R64.

38.

WWOX protein expression in normal human tissues.

Nunez MI, Ludes-Meyers J, Aldaz CM.

J Mol Histol. 2006 May;37(3-4):115-25. Epub 2006 Aug 29.

39.

Non-homologous end-joining defect in fanconi anemia hematopoietic cells exposed to ionizing radiation.

Casado JA, Núñez MI, Segovia JC, Ruiz de Almodóvar JM, Bueren JA.

Radiat Res. 2005 Nov;164(5):635-41.

PMID:
16238440
40.

Early and late skin reactions to radiotherapy for breast cancer and their correlation with radiation-induced DNA damage in lymphocytes.

López E, Guerrero R, Núñez MI, del Moral R, Villalobos M, Martínez-Galán J, Valenzuela MT, Muñoz-Gámez JA, Oliver FJ, Martín-Oliva D, Ruiz de Almodóvar JM.

Breast Cancer Res. 2005;7(5):R690-8. Epub 2005 Jul 1.

41.

PARP-1-dependent 3-nitrotyrosine protein modification after DNA damage.

Siles E, Martinez-Lara E, Núñez MI, Muñoz-Gámez JA, Martín-Oliva D, Valenzuela MT, Peinado MA, Ruiz de Almodóvar JM, Javier Oliver F.

J Cell Biochem. 2005 Nov 1;96(4):709-15.

PMID:
16052507
42.

WWOX protein expression varies among ovarian carcinoma histotypes and correlates with less favorable outcome.

Nunez MI, Rosen DG, Ludes-Meyers JH, Abba MC, Kil H, Page R, Klein-Szanto AJ, Godwin AK, Liu J, Mills GB, Aldaz CM.

BMC Cancer. 2005 Jun 27;5:64.

43.

[CA125 cytosolic levels in lung adenocarcinomas. New biological aspects].

Ruibal A, Nuñez Cambre I, Sánchez Salmón A, Nuñez MI, Rodríguez J.

Rev Esp Med Nucl. 2005 Jan-Feb;24(1):27-31. Spanish.

PMID:
15701343
44.

Frequent loss of WWOX expression in breast cancer: correlation with estrogen receptor status.

Nunez MI, Ludes-Meyers J, Abba MC, Kil H, Abbey NW, Page RE, Sahin A, Klein-Szanto AJ, Aldaz CM.

Breast Cancer Res Treat. 2005 Jan;89(2):99-105.

45.

PARP inhibition sensitizes p53-deficient breast cancer cells to doxorubicin-induced apoptosis.

Muñoz-Gámez JA, Martín-Oliva D, Aguilar-Quesada R, Cañuelo A, Nuñez MI, Valenzuela MT, Ruiz de Almodóvar JM, De Murcia G, Oliver FJ.

Biochem J. 2005 Feb 15;386(Pt 1):119-25.

46.

Crosstalk between PARP-1 and NF-kappaB modulates the promotion of skin neoplasia.

Martín-Oliva D, O'Valle F, Muñoz-Gámez JA, Valenzuela MT, Nuñez MI, Aguilar M, Ruiz de Almodóvar JM, Garcia del Moral R, Oliver FJ.

Oncogene. 2004 Jul 8;23(31):5275-83.

PMID:
15077172
47.

[CD44s expression in squamous cell lung carcinomas].

Ruibal A, Núñez MI, Rodríguez J.

Med Clin (Barc). 2004 Feb 21;122(6):237. Spanish. No abstract available.

PMID:
15012895
48.

[Cytosolic CA125 in lung squamous cell carcinomas].

Ruibal A, Núñez Cambre I, Núñez MI, Rodríguez J.

Rev Esp Med Nucl. 2004 Jan-Feb;23(1):46-8. Spanish. No abstract available.

PMID:
14718154
49.

Attention capture by auditory significant stimuli: semantic analysis follows attention switching.

Escera C, Yago E, Corral MJ, Corbera S, Nuñez MI.

Eur J Neurosci. 2003 Oct;18(8):2408-12.

PMID:
14622204
50.

Cytosolic levels of neuron-specific enolase in squamous cell carcinomas of the lung.

Ruibal A, Nuñez MI, Rodríguez J, Jiménez L, del Rio MC, Zapatero J.

Int J Biol Markers. 2003 Jul-Sep;18(3):188-94.

PMID:
14535589

Supplemental Content

Loading ...
Support Center